亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials

医学 雄激素剥夺疗法 前列腺癌 荟萃分析 肿瘤科 雄激素受体 骨质疏松症 内科学 雄激素 癌症 泌尿科 生物信息学 激素 生物
作者
Craig Jones,S. Gray,Michael D. Brown,Janet E. Brown,Eugène McCloskey,Bhavan Prasad,Noel W. Clarke,Ashwin Sachdeva
出处
期刊:European Urology Oncology [Elsevier BV]
卷期号:7 (5): 993-1004 被引量:21
标识
DOI:10.1016/j.euo.2024.01.016
摘要

The addition of androgen receptor signalling inhibitors (ARSIs) to standard androgen deprivation therapy (ADT) has improved survival outcomes in patients with advanced prostate cancer (PCa). Advanced PCa patients have a higher incidence of osteoporosis, compounded by rapid bone density loss upon commencement of ADT resulting in an increased fracture risk. The effect of treatment intensification with ARSIs on fall and fracture risk is unclear.To assess the risk of falls and fractures in men with PCa treated with ARSIs.A systematic review of EMBASE, MEDLINE, The Cochrane Library, and The Health Technology Assessment Database for randomised control trials between 1990 and June 2023 was conducted in accordance with Preferred Reporting Items for Systematic Review and Meta-analyses guidance. Risk ratios were estimated for the incidence of fracture and fall events. Subgroup analyses by grade of event and disease state were conducted.Twenty-three studies were eligible for inclusion. Fracture outcomes were reported in 17 studies (N = 18 811) and fall outcomes in 16 studies (N = 16 537). A pooled analysis demonstrated that ARSIs increased the risk of fractures (relative risk [RR] 2.32, 95% confidence interval [CI] 2.00-2.71; p < 0.01) and falls (RR 2.22, 95% CI 1.81-2.72; p < 0.01) compared with control. A subgroup analysis demonstrated an increased risk of both fractures (RR 2.13, 95% CI 1.70-2.67; p < 0.01) and falls (RR 2.19, 95% CI 1.53-3.12; p < 0.0001) in metastatic hormone-sensitive PCa patients, and an increased risk of fractures in the nonmetastatic (RR 2.27, 95% CI 1.60-3.20; p < 0.00001) and metastatic castrate-resistant (RR 2.85, 95% CI 2.16-3.76; p < 0.00001) settings. The key limitations include an inability to distinguish fragility from pathological fractures and potential for a competing risk bias.Addition of an ARSI to standard ADT significantly increases the risk of fractures and falls in men with prostate cancer.We found a significantly increased risk of both fractures and falls with a combination of novel androgen signalling inhibitors and traditional forms of hormone therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ceeray23应助科研通管家采纳,获得10
2秒前
ceeray23应助科研通管家采纳,获得10
2秒前
车访枫发布了新的文献求助10
11秒前
maidiniyati完成签到,获得积分10
19秒前
22秒前
27秒前
车访枫完成签到,获得积分10
37秒前
kin完成签到,获得积分10
44秒前
46秒前
49秒前
kin发布了新的文献求助10
49秒前
58秒前
uqq完成签到,获得积分10
58秒前
Jing发布了新的文献求助10
1分钟前
慕青应助Jing采纳,获得10
1分钟前
1分钟前
狗狗饲养员完成签到 ,获得积分10
1分钟前
null应助automan采纳,获得10
1分钟前
一方完成签到 ,获得积分10
1分钟前
领导范儿应助科研通管家采纳,获得10
2分钟前
我是老大应助科研通管家采纳,获得10
2分钟前
2分钟前
叶千山完成签到 ,获得积分10
2分钟前
2分钟前
lyt完成签到,获得积分10
2分钟前
lyt发布了新的文献求助10
2分钟前
2分钟前
喜悦的小土豆完成签到 ,获得积分10
2分钟前
过氧化氢发布了新的文献求助30
2分钟前
3分钟前
3分钟前
orixero应助FEI采纳,获得10
3分钟前
情怀应助帅气绮露采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
帅气绮露发布了新的文献求助10
3分钟前
3分钟前
阿玥完成签到 ,获得积分10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 1100
3O - Innate resistance in EGFR mutant non-small cell lung cancer (NSCLC) patients by coactivation of receptor tyrosine kinases (RTKs) 1000
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
Proceedings of the Fourth International Congress of Nematology, 8-13 June 2002, Tenerife, Spain 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5935720
求助须知:如何正确求助?哪些是违规求助? 7018838
关于积分的说明 15861624
捐赠科研通 5064672
什么是DOI,文献DOI怎么找? 2724193
邀请新用户注册赠送积分活动 1681888
关于科研通互助平台的介绍 1611414